Wiendl, Heinz, 1968-
Heinz Wiendl
Wiendl, Heinz
VIAF ID: 60216281 ( Personal )
Permalink: http://viaf.org/viaf/60216281
Preferred Forms
- 100 0 _ ‡a Heinz Wiendl
-
- 100 1 _ ‡a Wiendl, Heinz ‡d 1968-
- 100 1 _ ‡a Wiendl, Heinz ‡d 1968-
- 100 1 _ ‡a Wiendl, Heinz ‡d 1968-
- 100 1 _ ‡a Wiendl, Heinz, ‡d 1968-
4xx's: Alternate Name Forms (6)
5xx's: Related Names (1)
Works
Title | Sources |
---|---|
Alemtuzumab humanisierter monoklonaler Antikörper in der MS-Therapie | |
Association of smoking but not HLA-DRB1*15:01, APOE or body mass index with brain atrophy in early multiple sclerosis | |
Blockade of inhibitory killer cell immunoglobulin-like receptors and IL-2 triggering reverses the functional hypoactivity of tumor-derived NK-cells in glioblastomas | |
Cerebrospinal fluid concentrations of neuronal proteins are reduced in primary angiitis of the central nervous system | |
Classification of neurological diseases using multi-dimensional CSF analysis | |
CNS Pericytes Modulate Local T Cell Infiltration in EAE | |
Eculizumab versus rituximab in generalised myasthenia gravis | |
An enigmatic case of cortical anopsia: Antemortem diagnosis of a 14-3-3 negative Heidenhain-variant MM1-sCJD | |
Epoch analysis of on-treatment disability progression events over time in the Tysabri Observational Program (TOP) | |
Excitotoxic neuronal cell death during an oligodendrocyte-directed CD8+ T cell attack in the CNS gray matter | |
Fc-Receptor Targeted Therapies for the Treatment of Myasthenia gravis | |
Fragen und Antworten zur Neurologie = "Neurology secrets" | |
High-dimensional investigation of the cerebrospinal fluid to explore and monitor CNS immune responses | |
Humoral signatures of MOG-antibody-associated disease track with age and disease activity | |
Immune Cell Activation in the Cerebrospinal Fluid of Patients With Parkinson's Disease | |
Immunoadsorption versus double-dose methylprednisolone in refractory multiple sclerosis relapses | |
Immunregulatorische Eigenschaften des Muskels Implikationen für die Pathogenese entzündlicher Myopathien | |
Impact of disease-modifying therapies on humoral and cellular immune-responses following SARS-CoV-2 vaccination in MS patients | |
Impaired Autonomic Responses to Emotional Stimuli in Autoimmune Limbic Encephalitis | |
Increased Intrathecal B and Plasma Cells in Patients With Anti-IgLON5 Disease A Case Series | |
Independent risk factors for myasthenic crisis and disease exacerbation in a retrospective cohort of myasthenia gravis patients | |
Intratumor heterogeneity and T cell exhaustion in primary CNS lymphoma | |
Intravenous methadone causes acute toxic and delayed inflammatory encephalopathy with persistent neurocognitive impairments | |
JCV-Antikörpertestung bei MS-Patienten unter oder vor Therapie mit Natalizumab Ergebnisse eines Expertenmeetings, Düsseldorf, Juni 2011 | |
Longitudinal analyses of serum neurofilament light and associations with obesity indices and bioelectrical impedance parameters | |
MAPT genotype-dependent mitochondrial aberration and ROS production trigger dysfunction and death in cortical neurons of patients with hereditary FTLD | |
Multiple Sklerose Klinik, Diagnostik und Therapie | |
Ofatumumab neue Perspektiven für eine zielgerichtete Therapie der aktiven schubförmigen multiplen Sklerose | |
Profiling Complement System Components in Primary CNS Vasculitis | |
Risk and course of COVID-19 in immunosuppressed patients with myasthenia gravis | |
Severe disease exacerbation after mRNA COVID-19 vaccination unmasks suspected multiple sclerosis as neuromyelitis optica spectrum disorder: a case report | |
Single-cell profiling reveals preferential reduction of memory B cell subsets in cladribine patients that correlates with treatment response | |
Stroke induces disease-specific myeloid cells in the brain parenchyma and pia | |
Therapie und Verlauf neurologischer Erkrankungen | |
Translating insights from neuroimmunology into MS therapeutics, 2013: | |
Vaccination in multiple sclerosis patients treated with highly effective disease-modifying drugs: an overview with consideration of cladribine tablets |